Literature DB >> 1928334

In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans.

J N Clore1, P S Glickman, J E Nestler, W G Blackard.   

Abstract

To examine the effect of increased gluconeogenesis [by increasing free fatty acids (FFA)] on hepatic glucose output (HGO) and on the first substrate (glucose) cycle, a primed continuous infusion of [2-3H]- and [6-14C]glucose was infused to isotopic steady state in 12 normal male volunteers after an overnight fast. Blood samples for the determination of glucose specific activity were obtained before and after an infusion of saline (n = 6) or 10% Intralipid and heparin (90 mU.kg-1.min-1, n = 6). Plasma FFA (593.3 +/- 74.5 to 971.1 +/- 127.1 mumol/l, P = 0.007) and glycerol (68.0 +/- 5.9 vs. 222.4 +/- 32.0 mumol/l, P = 0.002) increased during the lipid infusion, and beta-hydroxybutyrate levels rose from 0.24 +/- 0.12 to 0.50 +/- 0.17 mmol/l (P = 0.01). No change in plasma glucose, insulin, or glucagon levels was observed during the study, and levels of the gluconeogenic substrates alanine and lactate were also unchanged. Baseline rates of glucose cycling (rate of appearance of [2-3H]glucose minus rate of appearance of [6-14C]glucose) were similar in the two groups [1.44 +/- 0.33 vs. 1.33 +/- 0.44 mumol.kg-1.min-1, not significant (NS)] and did not change during either saline or lipid infusion, respectively. However, Cori cycle activity (the conversion of [6-14C]- to [1-14C]glucose) increased significantly from 0.59 +/- 0.19 to 1.28 +/- 0.19 mumol.kg-1.min-1 (P = 0.002) after FFA and glycerol levels had been increased, in marked contrast to the saline control (0.51 +/- 0.18 to 0.39 +/- 0.18 mumol.kg-1.min-1, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928334     DOI: 10.1152/ajpendo.1991.261.4.E425

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

Review 1.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.

Authors:  X Chen; N Iqbal; G Boden
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 3.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

4.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.

Authors:  C A Chu; D K Sindelar; D W Neal; E J Allen; E P Donahue; A D Cherrington
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  S Andrikopoulos; J Proietto
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 7.  Role of ACE inhibitors in treating hypertensive diabetic patients.

Authors:  Dmitri Kirpichnikov; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction.

Authors:  Jeffrey D Browning; Brian Weis; Jeannie Davis; Santhosh Satapati; Matthew Merritt; Craig R Malloy; Shawn C Burgess
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 10.  Basal insulin therapy.

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.